Concurrent medical conditions, including hypertension, coronary artery disease, and AF, were similar between the two groups, except for CKD, which was higher in the SGLT2 inhibitor non-user group [11 (9.8%) vs. 12 (3.4%), p-value = 0.006]. The gene discussed is SLC5A2; the disease is chronic kidney disease.